No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
Jane Warwick, Emanuela Falaschetti, Kenneth Rockwood et al. · BMC Medicine · 2015 · Randomised trial
Full textCC BY